25 XP   0   0   10

Fisher & Paykel Healthcare Corporation Limited
Buy, Hold or Sell?

Let's analyse Fisher & Paykel Healthcare Corporation Limited together

PenkeI guess you are interested in Fisher & Paykel Healthcare Corporation Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fisher & Paykel Healthcare Corporation Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Fisher & Paykel Healthcare Corporation Limited

I send you an email if I find something interesting about Fisher & Paykel Healthcare Corporation Limited.

Quick analysis of Fisher & Paykel Healthcare Corporation Limited (30 sec.)










What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited? (30 sec.)

How much money do you get?

How much money do you get?
A$0.80
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$2.59
Expected worth in 1 year
A$3.12
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
A$1.77
Return On Investment
7.3%

For what price can you sell your share?

Current Price per Share
A$24.34
Expected price per share
A$21.79 - A$25.62
How sure are you?
50%

1. Valuation of Fisher & Paykel Healthcare Corporation Limited (5 min.)




Live pricePrice per Share (EOD)

A$24.34

Intrinsic Value Per Share

A$-0.98 - A$2.29

Total Value Per Share

A$1.61 - A$4.88

2. Growth of Fisher & Paykel Healthcare Corporation Limited (5 min.)




Is Fisher & Paykel Healthcare Corporation Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$974.3m$923.6m$50.6m5.2%

How much money is Fisher & Paykel Healthcare Corporation Limited making?

Current yearPrevious yearGrowGrow %
Making money$148.5m$223.7m-$75.1m-50.6%
Net Profit Margin16.8%24.8%--

How much money comes from the company's main activities?

3. Financial Health of Fisher & Paykel Healthcare Corporation Limited (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#47 / 170

Most Revenue
#32 / 170

Most Profit
#20 / 170

What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited? (5 min.)

Welcome investor! Fisher & Paykel Healthcare Corporation Limited's management wants to use your money to grow the business. In return you get a share of Fisher & Paykel Healthcare Corporation Limited.

What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited?

First you should know what it really means to hold a share of Fisher & Paykel Healthcare Corporation Limited. And how you can make/lose money.

Speculation

The Price per Share of Fisher & Paykel Healthcare Corporation Limited is A$24.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fisher & Paykel Healthcare Corporation Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fisher & Paykel Healthcare Corporation Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$2.59. Based on the TTM, the Book Value Change Per Share is A$0.13 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.31 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fisher & Paykel Healthcare Corporation Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.261.0%0.261.0%0.381.6%0.341.4%0.241.0%
Usd Book Value Change Per Share0.090.4%0.090.4%0.160.7%0.180.7%0.130.5%
Usd Dividend Per Share0.200.8%0.200.8%0.230.9%0.180.7%0.130.5%
Usd Total Gains Per Share0.291.2%0.291.2%0.391.6%0.361.5%0.261.1%
Usd Price Per Share16.09-16.09-14.53-15.59-10.42-
Price to Earnings Ratio63.03-63.03-37.80-49.08-42.13-
Price-to-Total Gains Ratio56.15-56.15-37.27-52.40-42.83-
Price to Book Ratio9.61-9.61-9.16-12.38-10.60-
Price-to-Total Gains Ratio56.15-56.15-37.27-52.40-42.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.752848
Number of shares63
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.200.18
Usd Book Value Change Per Share0.090.18
Usd Total Gains Per Share0.290.36
Gains per Quarter (63 shares)18.0522.39
Gains per Year (63 shares)72.2189.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1502262444580
2101441348990170
315166206133136260
420188278177181350
5251110350222226440
6302132422266271530
7352153494310317620
8402175566355362710
9453197638399407800
10503219710443452890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.03.00.087.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.01.00.095.8%

Fundamentals of Fisher & Paykel Healthcare Corporation Limited

About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Fundamental data was last updated by Penke on 2024-04-13 14:26:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Fisher & Paykel Healthcare Corporation Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fisher & Paykel Healthcare Corporation Limited earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 16.8% means that $0.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 16.8%. The company is making a huge profit. +2
  • The TTM is 16.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.8%TTM16.8%0.0%
TTM16.8%YOY24.8%-7.9%
TTM16.8%5Y22.7%-5.9%
5Y22.7%10Y20.5%+2.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ16.8%6.3%+10.5%
TTM16.8%6.5%+10.3%
YOY24.8%8.2%+16.6%
5Y22.7%7.3%+15.4%
10Y20.5%7.3%+13.2%
1.1.2. Return on Assets

Shows how efficient Fisher & Paykel Healthcare Corporation Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • 12.1% Return on Assets means that Fisher & Paykel Healthcare Corporation Limited generated $0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 12.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 12.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ12.1%TTM12.1%0.0%
TTM12.1%YOY19.3%-7.2%
TTM12.1%5Y19.4%-7.3%
5Y19.4%10Y18.6%+0.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ12.1%1.3%+10.8%
TTM12.1%1.4%+10.7%
YOY19.3%2.0%+17.3%
5Y19.4%2.2%+17.2%
10Y18.6%2.0%+16.6%
1.1.3. Return on Equity

Shows how efficient Fisher & Paykel Healthcare Corporation Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • 15.3% Return on Equity means Fisher & Paykel Healthcare Corporation Limited generated $0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 15.3%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 15.3%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.3%TTM15.3%0.0%
TTM15.3%YOY24.2%-9.0%
TTM15.3%5Y26.1%-10.8%
5Y26.1%10Y25.5%+0.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ15.3%2.6%+12.7%
TTM15.3%2.9%+12.4%
YOY24.2%3.9%+20.3%
5Y26.1%3.9%+22.2%
10Y25.5%4.0%+21.5%

1.2. Operating Efficiency of Fisher & Paykel Healthcare Corporation Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fisher & Paykel Healthcare Corporation Limited is operating .

  • Measures how much profit Fisher & Paykel Healthcare Corporation Limited makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 21.4% means the company generated $0.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 21.4%. The company is operating efficient. +1
  • The TTM is 21.4%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.4%TTM21.4%0.0%
TTM21.4%YOY28.4%-7.0%
TTM21.4%5Y28.7%-7.3%
5Y28.7%10Y27.7%+1.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ21.4%8.0%+13.4%
TTM21.4%7.3%+14.1%
YOY28.4%11.4%+17.0%
5Y28.7%10.1%+18.6%
10Y27.7%10.7%+17.0%
1.2.2. Operating Ratio

Measures how efficient Fisher & Paykel Healthcare Corporation Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are $0.79 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.786. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.786. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.786TTM0.7860.000
TTM0.786YOY0.716+0.070
TTM0.7865Y0.722+0.064
5Y0.72210Y0.773-0.051
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7861.129-0.343
TTM0.7861.124-0.338
YOY0.7161.090-0.374
5Y0.7221.100-0.378
10Y0.7731.060-0.287

1.3. Liquidity of Fisher & Paykel Healthcare Corporation Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.67 means the company has $2.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 2.671. The company is able to pay all its short-term debts. +1
  • The TTM is 2.671. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.671TTM2.6710.000
TTM2.671YOY2.922-0.250
TTM2.6715Y2.353+0.319
5Y2.35310Y2.235+0.118
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6712.323+0.348
TTM2.6712.387+0.284
YOY2.9222.582+0.340
5Y2.3532.631-0.278
10Y2.2352.627-0.392
1.3.2. Quick Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.30 means the company can pay off $1.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 1.297. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.297. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.297TTM1.2970.000
TTM1.297YOY2.213-0.917
TTM1.2975Y1.807-0.511
5Y1.80710Y1.666+0.142
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2971.113+0.184
TTM1.2971.148+0.149
YOY2.2131.296+0.917
5Y1.8071.427+0.380
10Y1.6661.527+0.139

1.4. Solvency of Fisher & Paykel Healthcare Corporation Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fisher & Paykel Healthcare Corporation Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.20 means that Fisher & Paykel Healthcare Corporation Limited assets are financed with 20.5% credit (debt) and the remaining percentage (100% - 20.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.205. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.205. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.205TTM0.2050.000
TTM0.205YOY0.203+0.002
TTM0.2055Y0.248-0.043
5Y0.24810Y0.269-0.021
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2050.354-0.149
TTM0.2050.357-0.152
YOY0.2030.358-0.155
5Y0.2480.362-0.114
10Y0.2690.373-0.104
1.4.2. Debt to Equity Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 25.7% means that company has $0.26 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.257. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.257. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.257TTM0.2570.000
TTM0.257YOY0.254+0.003
TTM0.2575Y0.334-0.077
5Y0.33410Y0.373-0.039
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2570.541-0.284
TTM0.2570.557-0.300
YOY0.2540.551-0.297
5Y0.3340.621-0.287
10Y0.3730.669-0.296

2. Market Valuation of Fisher & Paykel Healthcare Corporation Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Fisher & Paykel Healthcare Corporation Limited generates.

  • Above 15 is considered overpriced but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 63.03 means the investor is paying $63.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 61.716. Based on the earnings, the company is expensive. -2
  • The MRQ is 63.035. Based on the earnings, the company is expensive. -2
  • The TTM is 63.035. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD61.716MRQ63.035-1.319
MRQ63.035TTM63.0350.000
TTM63.035YOY37.803+25.231
TTM63.0355Y49.078+13.956
5Y49.07810Y42.134+6.945
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD61.71614.512+47.204
MRQ63.03517.788+45.247
TTM63.03518.314+44.721
YOY37.80322.147+15.656
5Y49.07820.547+28.531
10Y42.13424.933+17.201
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 1,336.943. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 1,365.506. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1,365.506. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1,336.943MRQ1,365.506-28.562
MRQ1,365.506TTM1,365.5060.000
TTM1,365.506YOY109.129+1,256.377
TTM1,365.5065Y346.329+1,019.176
5Y346.32910Y197.770+148.559
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD1,336.9439.665+1,327.278
MRQ1,365.5069.336+1,356.170
TTM1,365.5060.922+1,364.584
YOY109.1294.052+105.077
5Y346.3297.995+338.334
10Y197.7700.503+197.267
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fisher & Paykel Healthcare Corporation Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 9.61 means the investor is paying $9.61 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 9.413. Based on the equity, the company is overpriced. -1
  • The MRQ is 9.614. Based on the equity, the company is overpriced. -1
  • The TTM is 9.614. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.413MRQ9.614-0.201
MRQ9.614TTM9.6140.000
TTM9.614YOY9.158+0.456
TTM9.6145Y12.377-2.763
5Y12.37710Y10.599+1.778
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD9.4132.519+6.894
MRQ9.6142.759+6.855
TTM9.6142.827+6.787
YOY9.1583.284+5.874
5Y12.3773.524+8.853
10Y10.5994.198+6.401
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Fisher & Paykel Healthcare Corporation Limited.

3.1. Funds holding Fisher & Paykel Healthcare Corporation Limited

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2020-10-31Vanguard International Stock Index-Total Intl Stock Indx1.52-8750473--
2021-01-31Price (T.Rowe) International Discovery Fund0.93-5372634--
2020-12-31Smallcap World Fund0.82-4716500--
2020-12-31Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund0.63-3623676--
2021-01-31Invesco Oppenheimer International Small-Mid Company Fund0.49-2848208--
2020-12-31New Perspective Fund Inc0.47-2699000--
2021-02-28iShares Core MSCI EAFE ETF0.45-2606298--
2020-12-31American Funds Insurance Ser-Global Growth Fund0.44-2550000--
2020-12-31Columbia Acorn International Fund0.34999999-2013595--
2021-02-28iShares MSCI Eafe ETF0.33000002-1902697--
Total 6.4300000103708308100.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Fisher & Paykel Healthcare Corporation Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1340.1340%0.248-46%0.277-52%0.200-33%
Book Value Per Share--2.5862.5860%2.451+5%2.033+27%1.464+77%
Current Ratio--2.6712.6710%2.922-9%2.353+14%2.235+20%
Debt To Asset Ratio--0.2050.2050%0.203+1%0.248-17%0.269-24%
Debt To Equity Ratio--0.2570.2570%0.254+1%0.334-23%0.373-31%
Dividend Per Share--0.3080.3080%0.354-13%0.272+13%0.196+57%
Eps--0.3940.3940%0.594-34%0.519-24%0.372+6%
Free Cash Flow Per Share--0.0180.0180%0.206-91%0.250-93%0.207-91%
Free Cash Flow To Equity Per Share---0.292-0.2920%-0.166-43%-0.032-89%0.004-7704%
Gross Profit Margin---0.726-0.7260%-0.043-94%-0.254-65%-0.444-39%
Intrinsic Value_10Y_max--2.294--------
Intrinsic Value_10Y_min---0.976--------
Intrinsic Value_1Y_max--0.269--------
Intrinsic Value_1Y_min--0.132--------
Intrinsic Value_3Y_max--0.779--------
Intrinsic Value_3Y_min--0.200--------
Intrinsic Value_5Y_max--1.253--------
Intrinsic Value_5Y_min--0.051--------
Market Cap14170017410.560-2%14472745802.24014472745802.2400%13069716140.800+11%14025639254.528+3%9371772402.432+54%
Net Profit Margin--0.1680.1680%0.248-32%0.227-26%0.205-18%
Operating Margin--0.2140.2140%0.284-25%0.287-25%0.277-23%
Operating Ratio--0.7860.7860%0.716+10%0.722+9%0.773+2%
Pb Ratio9.413-2%9.6149.6140%9.158+5%12.377-22%10.599-9%
Pe Ratio61.716-2%63.03563.0350%37.803+67%49.078+28%42.134+50%
Price Per Share24.340-2%24.86024.8600%22.450+11%24.092+3%16.098+54%
Price To Free Cash Flow Ratio1336.943-2%1365.5061365.5060%109.129+1151%346.329+294%197.770+590%
Price To Total Gains Ratio54.976-2%56.15056.1500%37.273+51%52.401+7%42.834+31%
Quick Ratio--1.2971.2970%2.213-41%1.807-28%1.666-22%
Return On Assets--0.1210.1210%0.193-37%0.194-37%0.186-35%
Return On Equity--0.1530.1530%0.242-37%0.261-41%0.255-40%
Total Gains Per Share--0.4430.4430%0.602-26%0.549-19%0.396+12%
Usd Book Value--974306607.334974306607.3340%923672482.682+5%766072155.461+27%551759312.288+77%
Usd Book Value Change Per Share--0.0870.0870%0.160-46%0.179-52%0.129-33%
Usd Book Value Per Share--1.6741.6740%1.587+5%1.316+27%0.948+77%
Usd Dividend Per Share--0.2000.2000%0.229-13%0.176+13%0.127+57%
Usd Eps--0.2550.2550%0.384-34%0.336-24%0.241+6%
Usd Free Cash Flow--6859555.6666859555.6660%77511514.725-91%94124171.058-93%78169193.714-91%
Usd Free Cash Flow Per Share--0.0120.0120%0.133-91%0.162-93%0.134-91%
Usd Free Cash Flow To Equity Per Share---0.189-0.1890%-0.107-43%-0.020-89%0.002-7704%
Usd Market Cap9170835268.114-2%9366761083.2109366761083.2100%8458720286.326+11%9077393725.531+3%6065411098.854+54%
Usd Price Per Share15.753-2%16.08916.0890%14.530+11%15.592+3%10.419+54%
Usd Profit--148597242.968148597242.9680%223756695.464-34%195663920.645-24%140161277.153+6%
Usd Revenue--882732677.120882732677.1200%903161091.112-2%843631367.110+5%651278382.540+36%
Usd Total Gains Per Share--0.2870.2870%0.390-26%0.355-19%0.256+12%
 EOD+4 -4MRQTTM+0 -0YOY+7 -295Y+14 -2210Y+19 -17

4.2. Fundamental Score

Let's check the fundamental score of Fisher & Paykel Healthcare Corporation Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1561.716
Price to Book Ratio (EOD)Between0-19.413
Net Profit Margin (MRQ)Greater than00.168
Operating Margin (MRQ)Greater than00.214
Quick Ratio (MRQ)Greater than11.297
Current Ratio (MRQ)Greater than12.671
Debt to Asset Ratio (MRQ)Less than10.205
Debt to Equity Ratio (MRQ)Less than10.257
Return on Equity (MRQ)Greater than0.150.153
Return on Assets (MRQ)Greater than0.050.121
Total8/10 (80.0%)

4.3. Technical Score

Let's check the technical score of Fisher & Paykel Healthcare Corporation Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose23.860
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in NZD. All numbers in thousands.

Summary
Total Assets2,063,359
Total Liabilities422,219
Total Stockholder Equity1,641,140
 As reported
Total Liabilities 422,219
Total Stockholder Equity+ 1,641,140
Total Assets = 2,063,359

Assets

Total Assets2,063,359
Total Current Assets724,633
Long-term Assets1,338,727
Total Current Assets
Cash And Cash Equivalents 113,253
Short-term Investments 500
Net Receivables 237,925
Inventory 342,380
Other Current Assets 31,074
Total Current Assets  (as reported)724,633
Total Current Assets  (calculated)725,133
+/- 500
Long-term Assets
Property Plant Equipment 1,074,688
Intangible Assets 80,120
Long-term Assets Other 0
Long-term Assets  (as reported)1,338,727
Long-term Assets  (calculated)1,154,807
+/- 183,919

Liabilities & Shareholders' Equity

Total Current Liabilities271,246
Long-term Liabilities150,973
Total Stockholder Equity1,641,140
Total Current Liabilities
Short-term Debt 19,936
Short Long Term Debt 4,200
Accounts payable 40,247
Other Current Liabilities 204,885
Total Current Liabilities  (as reported)271,246
Total Current Liabilities  (calculated)269,268
+/- 1,977
Long-term Liabilities
Long term Debt 79,100
Capital Lease Obligations Min Short Term Debt42,564
Other Liabilities 36,800
Long-term Liabilities  (as reported)150,973
Long-term Liabilities  (calculated)158,464
+/- 7,491
Total Stockholder Equity
Common Stock287,345
Retained Earnings 1,123,639
Accumulated Other Comprehensive Income 233,245
Other Stockholders Equity -3,089
Total Stockholder Equity (as reported)1,641,140
Total Stockholder Equity (calculated)1,641,140
+/-0
Other
Capital Stock303,700
Cash and Short Term Investments 113,253
Common Stock Shares Outstanding 581,631
Current Deferred Revenue6,177
Liabilities and Stockholders Equity 2,063,359
Net Debt 23,212
Net Invested Capital 1,836,700
Net Tangible Assets 1,667,800
Net Working Capital 484,400
Property Plant and Equipment Gross 1,632,600
Short Long Term Debt Total 136,465



Balance Sheet

Currency in NZD. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-31
> Total Assets 
459,219
236,686
215,333
228,752
224,173
230,310
267,470
274,667
331,667
413,737
475,059
517,608
572,054
618,597
630,325
669,816
766,803
878,191
1,025,100
1,206,700
1,389,979
1,907,996
1,951,645
2,063,359
2,063,3591,951,6451,907,9961,389,9791,206,7001,025,100878,191766,803669,816630,325618,597572,054517,608475,059413,737331,667274,667267,470230,310224,173228,752215,333236,686459,219
   > Total Current Assets 
221,164
163,137
140,582
133,773
122,521
127,658
125,339
118,180
129,574
172,675
180,065
186,487
195,031
215,157
234,958
243,291
285,720
349,084
424,200
455,300
502,427
845,955
822,433
724,633
724,633822,433845,955502,427455,300424,200349,084285,720243,291234,958215,157195,031186,487180,065172,675129,574118,180125,339127,658122,521133,773140,582163,137221,164
       Cash And Cash Equivalents 
2,622
102,174
73,310
13,336
30,578
23,057
16,554
7,742
5,263
5,465
6,891
6,110
6,253
7,709
10,438
13,621
18,741
61,251
31,900
48,200
64,995
89,469
83,271
113,253
113,25383,27189,46964,99548,20031,90061,25118,74113,62110,4387,7096,2536,1106,8915,4655,2637,74216,55423,05730,57813,33673,310102,1742,622
       Short-term Investments 
0
0
0
35,000
17,000
14,000
12,000
0
2,865
6,256
21,443
14,871
21,050
28,360
33,141
23,776
11,524
19,330
100,400
92,500
75,262
257,740
185,253
500
500185,253257,74075,26292,500100,40019,33011,52423,77633,14128,36021,05014,87121,4436,2562,865012,00014,00017,00035,000000
       Net Receivables 
90,789
34,100
44,159
52,824
41,345
54,585
55,367
58,452
60,262
80,996
71,437
79,622
77,130
81,560
93,363
107,416
131,361
129,642
146,000
157,900
216,294
210,477
169,229
237,925
237,925169,229210,477216,294157,900146,000129,642131,361107,41693,36381,56077,13079,62271,43780,99660,26258,45255,36754,58541,34552,82444,15934,10090,789
       Inventory 
72,907
18,270
19,216
21,852
24,076
30,906
36,190
46,697
50,770
69,946
71,763
80,101
84,430
89,111
94,475
96,143
120,948
134,982
125,400
136,100
141,904
248,821
332,437
342,380
342,380332,437248,821141,904136,100125,400134,982120,94896,14394,47589,11184,43080,10171,76369,94650,77046,69736,19030,90624,07621,85219,21618,27072,907
       Other Current Assets 
54,846
8,593
3,897
10,761
9,522
5,110
5,228
5,289
10,414
10,012
8,531
5,783
6,168
8,417
3,541
2,335
3,146
3,879
20,500
20,600
3,971
39,447
52,241
31,074
31,07452,24139,4473,97120,60020,5003,8793,1462,3353,5418,4176,1685,7838,53110,01210,4145,2895,2285,1109,52210,7613,8978,59354,846
   > Long-term Assets 
0
73,549
74,751
94,979
101,652
102,652
142,131
156,487
202,093
241,062
294,994
331,121
377,023
403,440
395,367
426,525
481,083
529,107
600,900
751,400
887,552
1,062,041
1,129,213
1,338,727
1,338,7271,129,2131,062,041887,552751,400600,900529,107481,083426,525395,367403,440377,023331,121294,994241,062202,093156,487142,131102,652101,65294,97974,75173,5490
       Property Plant Equipment 
177,667
58,914
63,236
71,448
71,545
82,899
128,296
141,885
186,489
204,558
233,278
254,265
311,631
346,716
349,760
367,428
389,609
425,160
476,400
601,400
712,231
811,105
887,179
1,074,688
1,074,688887,179811,105712,231601,400476,400425,160389,609367,428349,760346,716311,631254,265233,278204,558186,489141,885128,29682,89971,54571,44863,23658,914177,667
       Goodwill 
1,657
2,955
1,133
2,185
1,800
1,415
1,030
645
1,030
1,030
1,030
1,030
1,030
1,450
1,450
1,450
0
0
0
0
0
0
0
0
000000001,4501,4501,4501,0301,0301,0301,0301,0306451,0301,4151,8002,1851,1332,9551,657
       Long Term Investments 
56,740
45,568
-889
0
0
0
0
0
0
0
0
0
0
0
777
17
10
22,059
900
400
0
0
0
0
000040090022,059101777700000000000-88945,56856,740
       Intangible Assets 
0
0
4,251
1,764
2,232
2,382
2,255
2,231
3,257
3,439
3,861
4,360
5,396
7,176
8,955
20,980
35,757
44,475
50,400
61,500
71,581
73,561
80,400
80,120
80,12080,40073,56171,58161,50050,40044,47535,75720,9808,9557,1765,3964,3603,8613,4393,2572,2312,2552,3822,2321,7644,25100
       Long-term Assets Other 
0
11,680
4,135
11,827
12,370
2,774
261
1,388
1,142
4,162
11,566
17,709
11,878
8,592
3,304
3,628
7,086
4,564
39,400
49,600
0
0
0
0
000049,60039,4004,5647,0863,6283,3048,59211,87817,70911,5664,1621,1421,3882612,77412,37011,8274,13511,6800
> Total Liabilities 
267,796
84,592
43,450
35,935
32,948
38,279
63,477
81,153
136,003
209,436
181,895
204,317
223,902
246,366
224,203
198,626
225,134
216,566
263,700
293,500
446,731
509,504
395,794
422,219
422,219395,794509,504446,731293,500263,700216,566225,134198,626224,203246,366223,902204,317181,895209,436136,00381,15363,47738,27932,94835,93543,45084,592267,796
   > Total Current Liabilities 
152,655
62,702
41,760
34,766
30,433
37,356
62,341
80,117
110,381
93,854
97,812
84,178
150,623
91,068
128,790
117,114
149,523
145,580
178,400
184,400
324,102
393,093
281,493
271,246
271,246281,493393,093324,102184,400178,400145,580149,523117,114128,79091,068150,62384,17897,81293,854110,38180,11762,34137,35630,43334,76641,76062,702152,655
       Short-term Debt 
94,465
77,052
2,727
3,106
6,326
8,065
23,841
40,845
65,007
23,447
24,502
17,110
80,230
17,136
45,786
14,154
16,286
21,091
29,900
17,300
89,307
24,459
15,747
19,936
19,93615,74724,45989,30717,30029,90021,09116,28614,15445,78617,13680,23017,11024,50223,44765,00740,84523,8418,0656,3263,1062,72777,05294,465
       Short Long Term Debt 
94,465
77,052
2,727
0
0
0
0
0
0
0
0
0
0
0
112,740
1,374
2,105
21,091
29,900
17,300
80,600
11,900
5,300
4,200
4,2005,30011,90080,60017,30029,90021,0912,1051,374112,740000000000002,72777,05294,465
       Accounts payable 
26,468
21,365
4,717
0
0
0
0
0
0
0
0
0
0
0
23,221
27,663
36,963
29,300
32,700
55,100
67,126
52,137
49,833
40,247
40,24749,83352,13767,12655,10032,70029,30036,96327,66323,221000000000004,71721,36526,468
       Other Current Liabilities 
31,722
54,206
33,393
22,983
13,297
14,216
19,327
23,365
30,714
46,730
50,498
45,951
47,887
52,793
59,783
75,297
96,274
95,169
115,800
112,000
133,380
178,938
186,365
204,885
204,885186,365178,938133,380112,000115,80095,16996,27475,29759,78352,79347,88745,95150,49846,73030,71423,36519,32714,21613,29722,98333,39354,20631,722
   > Long-term Liabilities 
0
21,890
1,690
1,169
2,515
923
1,136
1,036
25,622
115,582
84,083
120,139
73,279
155,298
95,413
81,512
75,611
70,986
85,300
109,100
122,628
116,411
114,301
150,973
150,973114,301116,411122,628109,10085,30070,98675,61181,51295,413155,29873,279120,13984,083115,58225,6221,0361,1369232,5151,1691,69021,8900
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,853
39,950
52,500
69,000
44,000
91,800
0
0
0091,80044,00069,00052,50039,95046,8530000000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,600
43,700
36,000
62,500
62,50036,00043,70033,60000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,297
0
0
0
0
0
0
00000014,29700000000000000000
> Total Stockholder Equity
191,423
152,094
171,883
192,817
191,225
192,031
203,993
193,514
195,664
204,301
293,164
313,291
348,152
372,231
406,122
471,190
541,669
661,625
761,400
913,200
943,248
1,398,492
1,555,851
1,641,140
1,641,1401,555,8511,398,492943,248913,200761,400661,625541,669471,190406,122372,231348,152313,291293,164204,301195,664193,514203,993192,031191,225192,817171,883152,094191,423
   Common Stock
0
152,094
171,883
171,065
174,558
195,622
204,239
193,514
3,647
4,076
13,000
38,719
63,305
91,280
120,373
145,871
163,244
181,830
198,400
219,200
221,815
231,074
246,665
287,345
287,345246,665231,074221,815219,200198,400181,830163,244145,871120,37391,28063,30538,71913,0004,0763,647193,514204,239195,622174,558171,065171,883152,0940
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-17,419
-2,021
-3,951
-3,591
-246
-53,868
3,349
12,499
84,103
89,852
100,821
86,033
61,238
58,548
50,571
88,759
95,700
144,800
60,152
223,075
219,803
233,245
233,245219,803223,07560,152144,80095,70088,75950,57158,54861,23886,033100,82189,85284,10312,4993,349-53,868-246-3,591-3,951-2,021-17,41900
   Capital Surplus 000000000000000000000000
   Treasury Stock00-2,200-3,600-1,800-3,000-1,662-2,3940000000000000000
   Other Stockholders Equity 
0
0
-112,205
0
0
0
0
0
0
0
0
0
0
0
61,238
58,548
12,089
88,800
95,700
144,800
-3,487
-2,023
-4,724
-3,089
-3,089-4,724-2,023-3,487144,80095,70088,80012,08958,54861,23800000000000-112,20500



Balance Sheet

Currency in NZD. All numbers in thousands.




Cash Flow

Currency in NZD. All numbers in thousands.